[Federal Register Volume 77, Number 177 (Wednesday, September 12, 2012)]
[Notices]
[Pages 56215-56216]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22384]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Target Discovery and Development Network.
    Date: October 18-19, 2012.
    Time: 6 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Special Review & Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Suite 703, Room 7072 Bethesda, MD 20892-8329, 301-594-1408, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Validation and Advanced Development of Emerging Technologies 
for Cancer Research.
    Date: October 30, 2012.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 56216]]

    Place: National Institutes of Health, 6120 Executive Boulevard, 
Room 511, Rockville, MD 20852.
    Contact Person: Thomas A. Winters, Ph.D., Scientific Review 
Officer, Special Review & Logistics Branch, Division of Extramural 
Activities, 6116 Executive Boulevard, Room 8146, National Cancer 
Institute, NIH, Bethesda, MD 20892-8329, 301-594-1566, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Quantitative Imaging for Evaluation of Responses to Cancer 
Therapies.
    Date: October 31, 2012.
    Time: 10 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 611, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8101 Bethesda, MD 20892-8329 301/496-7987 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Diagnostic and Therapeutic Agents Enabled by 
Nanotechnology.
    Date: November 27, 2012.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6120 Executive Boulevard, 
Room J, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Savvas C. Makrides, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard., Room 8050A Bethesda, MD 20892, 301-496-7421 
[email protected].

    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 6, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22384 Filed 9-11-12; 8:45 am]
BILLING CODE 4140-01-P